Chronic GastritisNCT07129824
Relationship Between Diet and Gastritis
An observational study of Chronic Gastritis, run by Sohag University at 1 site in Egypt.
Trial summary
Chronic gastritis (CG) is a prevalent and persistent inflammatory condition that affects the gastric mucosa, carrying a significant global burden. Although CG may remain asymptomatic in some cases, many patients experience gastrointestinal (GI) symptoms such as epigastric pain, bloating, nausea, vomiting, and appetite… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Chronic Gastritis
- What is being tested?
- Observation
- How many people
- 246 participants
- Where
- 1 siteEgypt
- Study dates
- Aug 2025to Aug 2026
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adults aged 18 years or above with gastrointestinal symptoms for a week or longer.
Who may be able to join
- • Adults aged 18 years or above
- All consecutive patients with gastrointestinal symptoms for a week or longer.
Who cannot join
- Subjects who reported having other digestive system diseases such as peptic ulcer, pancreatitis, hepatitis, and cirrhosis
- Serious heart, brain, liver, kidney, or hematopoietic system dysfunction or other serious diseases
- Severe mental illness (such as schizophrenia, depression, and anxiety)
- Food or drug allergies, pregnancy, or breastfeeding
- Symptoms that occurred after taking prescription or over-the-counter drugs, especially aspirin or other pain relievers.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Tasneem M Ali, Ass.Professor contact
Egypt1 site
Sohag university hospitals
Sohag, Sohag Governorate
Magdy M Amin, Professor, 0934602963, portal@med.sohag.edu.eg
About this study
Official title: Relationship Between Eating Habits, Food Preferences and Symptoms in Chronic Gastritis Patients
Chronic gastritis (CG) is a prevalent and persistent inflammatory condition that affects the gastric mucosa, carrying a significant global burden. Although CG may remain asymptomatic in some cases, many patients experience gastrointestinal (GI) symptoms such as epigastric pain, bloating, nausea, vomiting, and appetite loss.
Diet plays a crucial role in both the development and progression of CG. there is a significant relationship between dietary behaviors, GI symptoms, and quality of life (QoL) in CG patients. Poor dietary habits have been associated with increased symptom severity, while healthier eating behaviors correlate with better physical and mental well-being.
Most research has focused on dietary risk factors in gastric cancer patients, with limited studies exploring their impact on CG and its symptoms. Furthermore, while nutritional adjustments are frequently recommended in clinical practices such as reducing coffee and alcohol intake and avoiding heavy smoking, there is a lack of comprehensive studies evaluating the relationship between eating habits, food preferences, and symptom severity in CG patients
- Conditions
- Chronic Gastritis
- Being tested
- Observation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ObservationOther
Observe the effect of eating habits and food preferences on symptoms of chronic gastritis
| Study group | Role | What they receive |
|---|---|---|
| Chronic gastritis patients | Adults aged 18 years or above with gastrointestinal symptoms for a week or longer exclude who reported having other digestive system diseases such as peptic ulcer, pancreatitis, hepatitis, and cirrhosis also serious heart, brain, liver, kidney and hematopoietic system dysfunction. Severe mental illness (such as schizophrenia, depression, and anxiety), and food or drug allergies, pregnancy, or breastfeeding and symptoms that occurred after taking prescription or over-the-counter drugs, especially aspirin or other pain relievers are also excluded Receives: Other: Observation |
What is being measured
The primary outcome is the main question the study is designed to answer.
measure the percentage of patients with chronic gastritis who follow unhealthy dietary habits.
measure the percentage of patients with chronic gastritis who follow unhealthy dietary habits by standardized questionnaire consisted of three main sections:
- Sociodemographic Characteristics (age, sex, educational level, height, and weight).
- Gastrointestinal Symptoms (stomachache, gastric distention, hiccup, belching, heartburn, acid reflux, abdominal bloating, nausea, abdominal pain, vomiting, diarrhea, early satiety, appetite changes, food intake quantity, and symptom-related triggers)
- Dietary Factors (eating habits, food preferences)
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Aug 2025
- Study startAug 2025 (estimated)
- Primary completionAug 2026 (estimated)
- Study completionAug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Chronic GastritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 246 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ola Abdelmohsen Fathy, Sohag University
- Investigators
- Ola A fathy, Family medicine resident, Principal investigator, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07129824
- Sponsor's protocol ID
- Soh-Med--25-7-2MS
- Status last verified
- Aug 2025
- First submitted
- 9 Aug 2025
- Last updated
- 19 Aug 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Azer SA, Awosika AO, Akhondi H. Gastritis. 2024 Jun 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK544250/
PubMed 31334970